The oral-gut microbiota axis in cardiovascular diseases: mechanisms, therapeutic targets, and translational challenges
Frontiers in Cellular and Infection Microbiology · 25.09.2025 · 15
DOI: 10.3389/fcimb.2025.1658502 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 25.09.2025. Verfasst von Shuling Su und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Cardiovascular Diseases, Dysbiosis, Mouth. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province.
Abstract (Originalsprache)
The oral-gut microbiota axis, a newly recognized regulatory system, has emerged as a pivotal factor in the development of cardiovascular diseases (CVDs). This review comprehensively synthesizes the latest evidence on how the dysbiosis of oral and gut microbiota, along with their metabolic and immunological cross-talk, contributes to CVD pathogenesis, including atherosclerosis, hypertension, and heart failure. We highlight the novel “microbiota-metabolism-immunity”tri-dimensional regulatory network and explore innovative therapeutic strategies, such as precision microbiome modulation and non-invasive biomarker development. By bridging the gap between basic research and clinical translation, this review provides new insights into preventing and treating CVDs through targeting the oral-gut axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
- Shantou University Medical College, Shantou, Guangdong, China.
- Key Laboratory for Prevention and Control of Arrhythmia and Panvascular Disease, Shantou, Guangdong, China.
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province
Zitieren
APA
Su, S., Ni, X., & Lin, Y. (2025). The oral-gut microbiota axis in cardiovascular diseases: mechanisms, therapeutic targets, and translational challenges. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1658502
Vancouver
Su S, Ni X, Lin Y. The oral-gut microbiota axis in cardiovascular diseases: mechanisms, therapeutic targets, and translational challenges. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1658502
BibTeX
@article{Su2025,
author = {Su, Shuling and Ni, Xiaobin and Lin, Yongluan},
title = {The oral-gut microbiota axis in cardiovascular diseases: mechanisms, therapeutic targets, and translational challenges},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1658502}
}
EUVIMED